المؤلفون: Horwitz, S., O'connor, O. A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, Franck, Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T., Menne, T., Belada, D., Illés, Á., Tobinai, K., Tsukasaki, K., Yeh, S. P., Shustov, A., Hüttmann, A., Savage, K. J., Yuen, S., Zinzani, P. L., Miao, H., Bunn, V., Fenton, K., Fanale, M., Puhlmann, M., Illidge, T.

المساهمون: Université de Lille, CHU Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365

مصطلحات موضوعية: brentuximab vedotin, CHOP, frontline treatment, peripheral T-cell lymphoma, randomized clinical trial, overall survival

وصف الملف: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

Relation: Annals of Oncology; Ann Oncol; http://hdl.handle.net/20.500.12210/82443

الاتاحة: https://hdl.handle.net/20.500.12210/82443

المؤلفون: Horwitz S., O'Connor O. A., Pro B., Trumper L., Iyer S., Advani R., Bartlett N. L., Christensen J. H., Morschhauser F., Domingo-Domenech E., Rossi G., Kim W. S., Feldman T., Menne T., Belada D., Illes A., Tobinai K., Tsukasaki K., Yeh S. -P., Shustov A., Huttmann A., Savage K. J., Yuen S., Zinzani P. L., Miao H., Bunn V., Fenton K., Fanale M., Puhlmann M., Illidge T.

المساهمون: Horwitz S., O'Connor O.A., Pro B., Trumper L., Iyer S., Advani R., Bartlett N.L., Christensen J.H., Morschhauser F., Domingo-Domenech E., Rossi G., Kim W.S., Feldman T., Menne T., Belada D., Illes A., Tobinai K., Tsukasaki K., Yeh S.-P., Shustov A., Huttmann A., Savage K.J., Yuen S., Zinzani P.L., Miao H., Bunn V., Fenton K., Fanale M., Puhlmann M., Illidge T.

مصطلحات موضوعية: brentuximab vedotin, CHOP, frontline treatment, overall survival, peripheral T-cell lymphoma, randomized clinical trial

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/34921960; info:eu-repo/semantics/altIdentifier/wos/WOS:000755659500008; volume:33; issue:3; firstpage:288; lastpage:298; numberofpages:11; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/11585/904660; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85122922204; https://www.sciencedirect.com/science/article/pii/S0923753421048754

الاتاحة: https://hdl.handle.net/11585/904660
https://doi.org/10.1016/j.annonc.2021.12.002
https://www.sciencedirect.com/science/article/pii/S0923753421048754

المؤلفون: Savage K. J., Horwitz S. M., Advani R., Christensen J. H., Domingo-Domenech E., Rossi G., Morschhauser F., Alpdogan O., Suh C., Tobinai K., Shustov A., Trneny M., Yuen S., Zinzani P. L., Trumper L., Ilidge T., O'Connor O. A., Pro B., Miao H., Bunn V., Fenton K., Fanale M., Puhlmann M., Iyer S.

المساهمون: Savage K.J., Horwitz S.M., Advani R., Christensen J.H., Domingo-Domenech E., Rossi G., Morschhauser F., Alpdogan O., Suh C., Tobinai K., Shustov A., Trneny M., Yuen S., Zinzani P.L., Trumper L., Ilidge T., O'Connor O.A., Pro B., Miao H., Bunn V., Fenton K., Fanale M., Puhlmann M., Iyer S.

مصطلحات موضوعية: stem cell transplant, CD30+ PTCL, brentuximab vedotin, CHP, CHOP, ECHELON-2

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/35470385; info:eu-repo/semantics/altIdentifier/wos/WOS:000882627200005; volume:6; issue:19; firstpage:5550; lastpage:5555; numberofpages:6; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/904795; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85141324785; https://ashpublications.org/bloodadvances/article/6/19/5550/485057/Role-of-stem-cell-transplant-in-CD30-PTCL

الاتاحة: https://hdl.handle.net/11585/904795
https://doi.org/10.1182/bloodadvances.2020003971
https://ashpublications.org/bloodadvances/article/6/19/5550/485057/Role-of-stem-cell-transplant-in-CD30-PTCL

المؤلفون: Lee, H., Flinn, I. W., Melear, J., Ramchandren, R., Friedman, J., Burke, J. M., Linhares, Y., Raval, M., Chintapatla, R., Feldman, T. A., Yimer, H., Islas-Ohlmayer, M., Dean, A., Rana, V., Gandhi, M. D., Renshaw, J., Gillespie-Twardy, A. L., Ho, L., Puhlmann, M., Guo, W., Yasenchak, C. A.

المصدر: HemaSphere ; volume 6, page 979-980 ; ISSN 2572-9241

الاتاحة: http://dx.doi.org/10.1097/01.hs9.0000847224.76139.00
https://journals.lww.com/10.1097/01.HS9.0000847224.76139.00

المؤلفون: Hutchings, M., Ansell, S. M., Straus, D. J., Connors, J. M., Kim, W. S., Gallamini, A., Ramchandren, R., Friedberg, J. W., Advani, R., Evens, A. M., Smolewski, P., Savage, K. J., Bartlett, N. L., Eom, H.-S., Abramson, J. S., Dong, C., Campana, F., Fenton, K., Puhlmann, M., Radford, J.

المصدر: HemaSphere ; volume 6, page 101-102 ; ISSN 2572-9241

الاتاحة: http://dx.doi.org/10.1097/01.hs9.0000843692.94815.d7
https://journals.lww.com/10.1097/01.HS9.0000843692.94815.d7

المؤلفون: Collins, GP, Ansell, SM, Straus, DJ, Connors, JM, Dlugosz-Danecka, M, Kim, WS, Gallamini, A, Ramchandren, R, Friedberg, JW, Advani, R, Hutchings, M, Evens, AM, Smolewski, P, Savage, KJ, Bartlett, NL, Eom, HS, Abramson, JS, Feldman, T, Dong, C, Campana, F, Fenton, K, Puhlmann, M, Radford, John, Grp, ES

المساهمون: The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

Relation: Collins GP, Ansell SM, Straus DJ, Connors JM, Dlugosz-Danecka M, Kim WS, et al. Improved overall survival in stage III/ IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1. British journal of haematology. 2023 APR;201:105-. PubMed PMID: WOS:001049283000173. English.; http://hdl.handle.net/10541/626726; British Journal Of Haematology

الاتاحة: http://hdl.handle.net/10541/626726

المؤلفون: Straus, D., Radford, John A, Connors, J., Kim, W. S., Gallamini, A., Ramchandren, R., Friedberg, J., Advani, R., Hutchings, M., Evens, A., Smolewski, P., Savage, K., Bartlett, N., Eom, H. S., Abramson, J., Dong, C., Campana, F., Fenton, K., Puhlmann, M., Ansell, S.

المساهمون: Memorial Sloan Kettering Cancer Center, New York

Relation: Straus D, Radford J, Connors J, Kim WS, Gallamini A, Ramchandren R, et al. First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/ IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1. Clinical Lymphoma Myeloma & Leukemia. 2022 Oct;22:S350-S. PubMed PMID: WOS:000897948100362.; http://hdl.handle.net/10541/626142; Clinical Lymphoma Myeloma & Leukemia

الاتاحة: http://hdl.handle.net/10541/626142

المؤلفون: Ansell, S. M., Connors, J. M., Radford, John A, Kim, W. S., Gallamini, A., Ramchandren, R., Friedberg, J. W., Advani, R. H., Hutchings, M., Evens, A. M., Smolewski, P., Savage, K. J., Bartlett, N. L., Eom, H. S., Abramson, J. S., Dong, C., Campana, F., Fenton, K., Puhlmann, M., Straus, D. J.

المساهمون: Mayo Clinic, Rochester, MN

Relation: https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.7503; Ansell SM, Connors JM, Radford JA, Kim WS, Gallamini A, Ramchandren R, et al. First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680301966.; http://hdl.handle.net/10541/625813; Journal of Clinical Oncology

الاتاحة: http://hdl.handle.net/10541/625813
https://doi.org/10.1200/JCO.2022.40.16_suppl.7503

المؤلفون: de Wit, R., Vaughn, D.J., Fradet, Y., Lee, J-L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W.R., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Mai, Y., Puhlmann, M., Perini, R.F., Bellmunt, J., Bajorin, D.F.

المصدر: Annals of Oncology ; volume 28, page v623 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdx440.031
https://api.elsevier.com/content/article/PII:S0923753420391316?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753420391316?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx440.031/19941848/mdx440.031.pdf

المؤلفون: Ansell, S. M., Radford, John A, Connors, J. M., Długosz-Danecka, M., Kim, W. S., Gallamini, A., Ramchandren, R., Friedberg, J. W., Advani, R., Hutchings, M., Evens, A. M., Smolewski, P., Savage, K. J., Bartlett, N. L., Eom, H. S., Abramson, J. S., Dong, C., Campana, F., Fenton, K., Puhlmann, M., Straus, D. J.

المساهمون: Division of Hematology, Mayo Clinic, Rochester, MN

Relation: https://dx.doi.org/10.1056/NEJMoa2206125; Ansell SM, Radford J, Connors JM, Długosz-Danecka M, Kim WS, Gallamini A, et al. Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma. The New England journal of medicine. 2022 Jul 13. PubMed PMID: 35830649. Epub 2022/07/14. eng.; http://hdl.handle.net/10541/625427; New England Journal of Medicine

الاتاحة: http://hdl.handle.net/10541/625427
https://doi.org/10.1056/NEJMoa2206125

المؤلفون: Jochheim H, Puhlmann M, Beese F, Berthold D, Einert P, Kallweit R, Konopatzky A, Meesenburg H, Meiwes K-J, Raspe S, Schulte-Bisping H, Schulz C

المصدر: iForest - Biogeosciences and Forestry, Vol 2, Iss 1, Pp 7-10 (2009)

مصطلحات موضوعية: Monitoring, Carbon budget, Modelling, Climate change, Forestry, SD1-669.5

وصف الملف: electronic resource

Relation: https://iforest.sisef.org/contents/?id=ifor0475-002; https://doaj.org/toc/1971-7458

URL الوصول: https://doaj.org/article/194a5ba5a66e4c179553c275dd59cb8c

المؤلفون: Zinzani, P. L., Illidge, T., Horwitz, S. M., O'Connor, O. A., Pro, B., Iyer, S. P., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T. A., Menne, T., Belada, D., Illes, A., Tobinai, K., Tsukasaki, K., Yeh, S-P., Huttmann, A., Savage, K. J., Yuen, S., Miao, H., Bunn, V., Fenton, K., Fanale, M. A., Puhlmann, M., Trumper, L.

المصدر: Zinzani , P L , Illidge , T , Horwitz , S M , O'Connor , O A , Pro , B , Iyer , S P , Advani , R , Bartlett , N L , Christensen , J H , Morschhauser , F , Domingo-Domenech , E , Rossi , G , Kim , W S , Feldman , T A , Menne , T , Belada , D , Illes , A , Tobinai , K , Tsukasaki , K , Yeh , S-P , Huttmann , A , Savage , K J , Yuen , ....

Relation: https://portal.findresearcher.sdu.dk/da/publications/d13b2c46-5c6b-482c-b508-9f2b755dfe65

الاتاحة: https://portal.findresearcher.sdu.dk/da/publications/d13b2c46-5c6b-482c-b508-9f2b755dfe65
https://doi.org/10.3324/haematol.2021.s3

المؤلفون: Illidge, Timothy M, Horwitz, S. M., O'Connor, O. A., Pro, B., Iyer, S. P., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T. A., Menne, T., Belada, D., Illes, A., Tobinai, K., Tsukasaki, K., Yeh, S. P., Huttmann, A., Savage, K. J., Yuen, S., Zinzani, P. L., Miao, H., Bunn, V., Fenton, K., Fanale, M. A., Puhlmann, M, Trumper, L.

المساهمون: Division of Cancer Services, Faculty of Biology, Medicine and Health, University of Manchester, NIHR Biomedical Research Centre, Manchester Academic Health Sciences Centre, Christie Hospital NHS Foundation Trust, Manchester

Relation: Illidge T, Horwitz SM, O'Connor OA, Pro B, Iyer SP, Advani R, et al. ECHELON-2 (NCT01777152), a randomized, double-blind, phase 3 study of brentuximab vedotin plus cyclophosphamide doxorubicin and prednisone versus cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with CD30-positive peripheral T-cell lymphoma: 5-year results. British Journal of Haematology. 2021;193:38-40.; http://hdl.handle.net/10541/624071; British Journal of Haematology

الاتاحة: http://hdl.handle.net/10541/624071

المؤلفون: Matulonis, U.A., Chen, M., Puhlmann, M., Shentu, Y., Ledermann, J.

المصدر: Annals of Oncology ; volume 27, page vi311 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdw374.47
https://api.elsevier.com/content/article/PII:S0923753419445274?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419445274?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/27/suppl_6/900TiP/19450805/mdw374.47.pdf

المؤلفون: Trumper, L., Pro, B., Horwitz, S., O'Connor, O., Tilly, H., Choi, I., Gritti, G., Fox, C., Alpdogan, O., Mayer, J., Briones, J., Jacobsen, E., Pezzutto, A., Demeter, J., Gurion, R., Jurczak, W., Kuo, C. Y., Opat, S., Little, M., Brown, L., Puhlmann, M., Illidge, Timothy M

المساهمون: Univ Med Gottingen, Gottingen, Germany

Relation: Trumper L, Pro B, Horwitz S, O'Connor O, Tilly H, Choi I, et al. Exploratory analysis of retreatment with brentuximab vedotin (BV) after frontline treatment with brentuximab vedotin and CHP (A plus CHP) for patients (pts) with CD30+peripheral T-cell lymphoma (ECHELON-2). Oncology Research and Treatment. 2020;43(SUPPL 4):119-; http://hdl.handle.net/10541/623444; Oncology Research and Treatment

الاتاحة: http://hdl.handle.net/10541/623444

المؤلفون: Franko, Uwe, Russow, Rolf, Puhlmann, M., Schulz, Horst

المساهمون: Franko, U.

المصدر: ISSN: 0948-9452 ; Leipzig - Reportsammlung, Bibliothek, 00032483, 02-1529 F/E.

وصف الملف: application/pdf

Relation: https://www.ufz.de/index.php?en=20939&ufzPublicationIdentifier=5488

الاتاحة: https://www.ufz.de/index.php?en=20939&ufzPublicationIdentifier=5488

المؤلفون: Kaye, S.B., Siu, L.L., Jassem, J., Medioni, J., Soetekouw, P. M.M.B., Slater, S., Rudin, C. M., Schwartz, G.K., De Jonge, M., O'Dwyer, P., Baudelet, C., Chen, A., Ratain, M. J., Aghajanian, C., Nycum, L.R., Goff, B., Nguyen, H., Husain, A., Blank, S.V., Ayers, S., Tun, T.T., Mescallado, N., Wright, A., Evans, D.G.R., Clamp, A., Jayson, G.C., Hasan, J., Supernat, A.M., Urban, Z., Lapinska-Szumczyk, S., Sawicki, S., Wydra, D., Zaczek, A.J., Milewski, L., Dabrowska, Z., Bodnar, L., Synowiec, A., Szczylik, C., Malejczyk, J., George, A., Tunariu, N., Wilkinson, N., Gupta, S., Gore, M.E., Banerjee, S., Harano, K., Shiroiwa, T., Watanabe, M., Suzuki, K., Fukuda, T., Watanabe, S., Katsumata, N., Liu, J., Patel, R., Kato, G., Matulonis, U., Moyo, V., Riahi, K., Pearlberg, J., Czibere, A., Isakoff, S., Vergote, I.B., Benzaquen, A. Oaknin, Baurain, J., Ananda, S., Wong, S., Yang, X., Wu, B., Zhong, Z., Puhlmann, M., Casado, A., Lueck, H., Ewald-Riegler, N., De Gregorio, N., Reuss, A., Mahner, S., Fotopoulou, C., Kommoss, F., Schmalfeldt, B., Hauptmann, S., Du Bois, A., Morice, P., Kane, A., Muller, E., Fauvet, R., Gouy, S., Pautier, P., Lhomme, C., Darai, E., Duvillard, P., Uzan, C., Mendiola, C., Davidenko, I., Colombo, N., Korach, J., Selle, F., Gocze, P., Chmielowska, E., Bollag, D., Oza, A.M., Bodnar, A. Gasowska-, Jerzak, M., Wcislo, G., Cichowicz, M., Dabek, A., Kozlowski, W., Baranowski, W., Sehouli, J., Zeimet, A., Scambia, G., Zang, R., Meier, W., Greggi, S., Lécuru, F., Harter, P., Mehta, J., Olivares, R., Moulard, O., Trask, P., Hamed, A., Raja, F.A., Counsell, N., Parmar, M.K., Pfisterer, J., Martin, A. Gonzalez, Alberts, D., Plante, M., Ledermann, J.A., Chow, S., Romero, I., Pujade-Lauraine, E., Tanovic, A., García, J. Gómez, Poveda, A.M., Ahmedov, O.M., Yuldasheva, N.S., Umarova, N., Ghanem, I., Diaz, A., Velasco, G., Manso, L., Ciruelos, E., Manneh, R.A., Hoyos, S., Pascual, T., Cortes-Funes, H., Makar, A.P., Vandecasteele, K., Tummers, P., Ost, P., Delrue, L., Van Belle, S., Van den Broecke, R., Fonteyne, V., De Never, W., De Meerleer, G., Kelly, Z., Pandha, H., Morgan, R., Michael, A., Nishio, S., Shimada, M., Kamura, T., Ishitani, K., Ochiai, K., Takeshima, N., Yokoyama, Y., Furumoto, H., Sugiyama, T., Kigawa, J., Ulker, M., Duman, B.B., Sahin, B., Gumurdulu, D., Nicoletto, M.O., Furini, L., Palma, M. Dalla, Borgato, L., Fiduccia, P., Rocchetto, M., Nardelli, G.B., Gervasi, M.T., Zagonel, V., Dean, E., Jayson, G., Goonetilleke, D., Conway, A., Ray-Coquard, I., Alexandre, J., Vacher-Lavenu, M., Fabbro, M., Floquet, A., Ferron, G., Chiannilkulchai, N., Hannan, A., Siddiqui, N., Badar, F., Tanabe, H., Kitagawa, R., Shibata, T., Saito, M., Takakura, S., Okamoto, A., Sasaki, H., Yoshikawa, H., Yousif, N.G., Kamiran, J., Yousif, M.G., Anderson, S., Albaghdadi, J., Majumder, R., Mukhopadhyay, A., Poddar, S., Sen, A.N., Gupta, P., Navruzova, V., Elmajjaoui, S., Ismaili, N., Hassouni, K., Kebdani, T., Benjaafar, N., Villar, M. Vieito, Lago, N. Martinez, Cueva, J.F., Patiño, E. Gonzalez, Curiel, M.T., Ozores, P. Palacios, Folgar, S. Candamio, Garrido, N. Salvador, Taboada, B., Lopez, R., Lobbedez, F. Joly, Melichar, B., Kutarska, E., Hall, G., Reed, N., Barney, B., Petersen, I.A., Call, J.A., Grothey, A., Haddock, M.G., Flores-Balcázar, C., Alvarado-Zermeño, A., Blake-Cerda, M., Mota-García, A., Poitevin-Chacón, A., Rosales-Pérez, S., Trejo-Duran, G., Mancini, M., Ramondino, S., Di Rocco, R., Ratti, M., Lorusso, D., Raspagliesi, F., Bianconi, M.I., Otero, S., Moscheni, O., Alvarez, L., Storino, C., Jankilevich, G., Wessels, R., De Bruin, D.M., Faber, D.J., van Boven, H.H., Vincent, A.D., van Leeuwen, T.G., van Beurden, M., Ruers, T.J.M., Speelers, B., Navruzov, S., Caires, I.Q.S., Lima, R.C.A.D., Barroso-Sousa, R., Andrade, E.M.P.D., Silva, J.R.D., Sanchez, F.B., Hoff, P.M., Diz, M., Garces, A.H. Ingles, Mora, P., Alves, F., Mangia, A., Calazan, C., Rodrigues, A., Melo, A., Kannan, K., Sridharan, N., Neelakantan, R. Pourrli, Kang, B., Noh, S., Lee, S., Ben Fatma, L., Said, S., Boudagga, M., Hochlef, M., Zairi, F., Khairi, H., Gharbi, O., Boussen, H., Ben Ahmed, S, Mansi, L., Kalbacher, E., Demarchi, M., Bazan, F., Schneider, M., Vuillemin, A., Bernhard, S., Nerich, V., Borg, C., Pivot, X., Durnali, A., Tokluog lu, S., Ozdemir, N., Inanc, M., Alkis, N., Zengin, N., Sonmez, O.U., Kucukoner, M., Ozkan, M., Oksuzoglu, B.

مصطلحات موضوعية: Submitted abstracts

وصف الملف: text/html

Relation: http://annonc.oxfordjournals.org/cgi/content/short/23/suppl_9/ix319; http://dx.doi.org/10.1093/annonc/mds401

الاتاحة: http://annonc.oxfordjournals.org/cgi/content/short/23/suppl_9/ix319
https://doi.org/10.1093/annonc/mds401

المؤلفون: Vergote, I.B., Benzaquen, A. Oaknin, Baurain, J., Ananda, S., Wong, S., Yang, X., Wu, B., Zhong, Z., Puhlmann, M., Casado, A.

المصدر: Annals of Oncology ; volume 23, page ix321-ix322 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/s0923-7534(20)33578-x
https://api.elsevier.com/content/article/PII:S092375342033578X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S092375342033578X?httpAccept=text/plain

المؤلفون: McCart, JA, Puhlmann, M, Lee, J, Hu, Y, Libutti, SK, Alexander, HR, Bartlett, DL

المصدر: Gene Therapy ; volume 7, issue 14, page 1217-1223 ; ISSN 0969-7128 1476-5462

الاتاحة: http://dx.doi.org/10.1038/sj.gt.3301237
https://www.nature.com/articles/3301237.pdf
https://www.nature.com/articles/3301237

المؤلفون: Gnant, M. F. X., Noll, L. A., Irvine, K. R., Puhlmann, M., Terrill, R. E., Alexander, H. R., Bartlett, D. L.

المصدر: JNCI Journal of the National Cancer Institute ; volume 91, issue 20, page 1744-1750 ; ISSN 0027-8874 1460-2105

الاتاحة: http://dx.doi.org/10.1093/jnci/91.20.1744
http://academic.oup.com/jnci/article-pdf/91/20/1744/7795558/1744.pdf